About Benjamin Enerson
Form D filings for Lennham Pharmaceuticals from 2021 to 2023 list Benjamin Enerson as executive officer.
Benjamin Enerson first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Benjamin Enerson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Benjamin Enerson works with at each company, as listed on that company's latest Form D.
Lennham Pharmaceuticals, Inc. · Form D, Apr 4, 2023
BS
Bradford Sippy
CEO and director
CM
Corey MacGregor
Executive officer